Nanoligent is a company whose goal is to develop new anticancer drugs specifically targeting aggressive tumors, using a pioneering technological platform based on protein–drug nanoconjugates. The co...
The Aortyx team is developing a minimally invasive solution for aortic dissection, essentially a tear in the aortic wall. To this end, they have created a steerable catheter that is inserted through t...
MiMARK Diagnostics, S.L. a pioneering femtech spin-off from the Vall d'Hebron Research Institute (VHIR), has successfully raised €4.22 million as seed round stage. The substantial investment will dr...
Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...